Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face

PHASE3CompletedINTERVENTIONAL
Enrollment

557

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

March 3, 2021

Study Completion Date

April 7, 2021

Conditions
Actinic Keratoses
Interventions
DRUG

MAL 16.8% cream

Day light photodynamic therapy with MAL 16.8% cream

DRUG

MAL Vehicle Cream

Day light photodynamic therapy with MAL vehicle cream

Trial Locations (60)

10022

Galderma Investigational Site (Site 8733), New York

10075

Galderma Investigational Site (Site 8279), New York

11203

Galderma Investigational Site (Site 8242), Brooklyn

15213

Galderma Investigational Site (Site 8721), Pittsburgh

18249

Galderma Investigational Site (Site 8754), Sugarloaf

19103

Galderma Investigational Site (Site 8255), Philadelphia

24501

Galderma Investigational Site (Site 8057), Lynchburg

26505

Galderma Investigational Site (Site 8725), Morgantown

28277

Galderma Investigational Site (Site 8566), Charlotte

29407

Galderma Investigational Site (Site 8777), Charleston

30342

Galderma Investigational Site (Site 8860), Atlanta

31904

Galderma Investigational Site (Site 8667), Columbus

32771

Galderma Investigational Site (Site 8529), Sanford

33028

Galderma Investigational Site (Site 8734), Pembroke Pines

33137

Galderma Investigational Site (Site 8656), Miami

33162

Galderma Investigational Site (Site 8765), North Miami Beach

33401

Galderma Investigational Site (Site 8126), West Palm Beach

33461

Galderma Investigation Site (Site 8769), Palm Springs

33936

Galderma Investigational Site (Site 8770), Lehigh Acres

34209

Galderma Investigational Site (Site 8479), Bradenton

37215

Galderma Investigational Site (Site 8207), Nashville

40241

Galderma Investigational Site (Site 8724), Louisville

43016

Galderma Investigational Site (Site 8595), Dublin

49085

Galderma Investigation Site (Site 8757), Saint Joseph

55112

Galderma Investigational Site (Site 8140), New Brighton

60561

Galderma Investigational Site (Site 8838), Darien

63141

Galderma Investigational Site (Site 8219), St Louis

Galderma Investigational Site (Site 8869), St Louis

68144

Galderma Investigational Site (Site 8048), Omaha

75034

Galderma Investigational Site (Site 8664), Frisco

77056

Galderma Investigational Site (Site # 8576), Houston

77845

Galderma Investigational Site (Site 8139), College Station

78759

Galderma Investigational Site (Site 8076), Austin

80111

Galderma Investigational Site (Site 8440), Greenwood Village

80210

Galderma Investigational Site (Site 8778), Denver

83704

Galderma Investigational Site (Site 8755), Boise

84101

Galderma Investigational Site (Site 8761), West Jordan

84117

Galderma Investigational Site (Site 8672), Salt Lake City

84790

Galderma Investigational Site (Site 8776), St. George

85718

Galderma Investigational Site (Site 8768), Tucson

87102

Galderma Investigational Site (Site 8759), Albuquerque

90404

Galderma Investigational Site (Site 8608), Santa Monica

92024

Galderma Investigational Site (Site 8577), Encinitas

92121

Galderma Investigational Site (Site 8758), San Diego

92708

Galderma Investigational Site (Site 8636), Fountain Valley

93720

Galderma Investigational Site (Site 8114), Fresno

94538

Galderma Investigational Site (Site 8224), Fremont

98168

Galderma Investigational Site (Site 8779), Burien

99202

Galderma Investigational Site (Site 8039), Spokane

Galderma Investigational Site (Site 8760), Spokane

72916-6103

Galderma Investigational Site (Site 8447), Fort Smith

30342-1418

Galderma Investigational Site (Site 8683), Atlanta

01915

Galderma Investigational Site (Site 8208), Beverly

48346-3198

Galderma Investigational Site (Site 8574), Clarkston

55424-1200

Galderma Investigational Site (Site 8762), Edina

03801

Galderma Investigational Site (Site 8420), Portsmouth

28405-3176

Galderma Investigational Site (Site 8726), Wilmington

97210-2996

Galderma Investiational Site (Site 8212), Portland

78660-3519

Galderma Investigational Site (Site 8546), Pflugerville

00705

Galderma Investigational Site (Site 8231), Aibonito

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT04085367 - Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face | Biotech Hunter | Biotech Hunter